Skip to main content
Log in

Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Mammaglobin-A is exclusively expressed by breast cancer cells. Thus, mammaglobin-A-specific T cell immune responses may be useful for the design of new breast cancer-specific immunotherapies. We show herein that CD8+ T cells generated against recombinant mammaglobin-A-pulsed dendritic cells display a marked cytotoxic activity against mammaglobin-A-positive breast cancer cell lines. This study indicates the immunotherapeutic potential of this novel antigen for the treatment of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Watson MA, Fleming TP: Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54: 4598–4602, 1994

    Google Scholar 

  2. Watson MA, Fleming TP: Mammaglobin, a mammary specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56: 860–865, 1996

    Google Scholar 

  3. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16: 817–824, 1998

    Google Scholar 

  4. Fleming TP, Watson MA: Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann NY Acad Sci 923: 78–89, 2000

    Google Scholar 

  5. Marchetti A, Buttitta F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F: mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol 195: 186–190, 2001

    Google Scholar 

  6. Grunewald K, Haun M, Urbanek M, Fiegel M, Muller-Holzner E, Gunsilius E, Dunser M, Marth C, Castle G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal growth factor receptor and cytokeratin-19. Lab Invest 80: 1071–1077, 2000

    Google Scholar 

  7. Paik S, Burkhard E, Lippman ME: Clinical significance of erb/b2 protein overexpression. Cancer Treat Res 61: 181–191, 1992

    Google Scholar 

  8. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. P Natl Acad Sci USA 90: 1112–1116, 1993

    Google Scholar 

  9. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP: Mammaglobin expression in primary, metastatic and occult breast cancer. Cancer Res 59: 3028–3031, 1999

    Google Scholar 

  10. Zhou JL, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. P Natl Acad Sci USA 93: 2588–2592, 1996

    Google Scholar 

  11. Jaramillo A, Majunder K, Manna PP, Fleming TP, Doherty G, Dipersio JF, Mohanakumar T: Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer 102: 499–506, 2002

    Google Scholar 

  12. Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12: 735–773, 1994

    Google Scholar 

  13. Bevan MJ: Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 182: 639–641, 1995

    Google Scholar 

  14. Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee H-G, Kanz L, Brugger W: Her-2/neu derived peptides are tumor associated antigens expressed by human renal cell and colon carcinomalines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res 58: 732–736, 1998

    Google Scholar 

  15. Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E: Identification of HLA-A3 restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and Her-2/neu by primary in vitro immunization with peptide pulsed dendritic cells. Cancer Res 59: 431–435, 1999

    Google Scholar 

  16. Cella M, Sallusto F, Lanzavecchia L: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10–16, 1997

    Google Scholar 

  17. Zitovogel L, Mayordoma JI, Storkus WJ, Lotze MT, Falo LD: Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell associated cytokines. J Exp Med 183: 87–97, 1996

    Google Scholar 

  18. Pagalia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J ExpMed 183: 317–322, 1996

    Google Scholar 

  19. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E: Bone marrow generated dendritic cells pulsed with tumor extract or tumor RNA induce anti-tumor immunity against central nervous system tumors. J Exp Med 186: 1177–1182, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manna, P.P., Jaramillo, A., Majumder, K. et al. Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells. Breast Cancer Res Treat 79, 133–136 (2003). https://doi.org/10.1023/A:1023323509888

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023323509888

Navigation